Accessing antiretroviral therapy following release from prison.
about
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparitiesHIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community careEarly identification of HIV: empirical support for jail-based screeningRetention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersHIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity.Emergency department use by released prisoners with HIV: an observational longitudinal study.Gender Differences in HIV Care among Criminal Justice-Involved Persons: Baseline Data from the CARE+ Corrections StudyIncarceration as a key variable in racial disparities of asthma prevalenceHigh mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV.Integrating correctional and community health care for formerly incarcerated people who are eligible for MedicaidSurvey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment.Commentary on Larney (2010): a call to action-opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners.Cohort profile: seek, test, treat and retain United States criminal justice cohortA description of an urban transitions clinic serving formerly incarcerated people.Manifestations of HIV stigma and their impact on retention in care for people transitioning from prisons to communities.Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, CaliforniaA high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study, 2002 to 2010.Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.Prevalence of chronic medical conditions among inmates in the Texas prison system.The role of jails in engaging PLWHA in care: from jail to community.Health status, sexual and drug risk, and psychosocial factors relevant to postrelease planning for HIV+ prisoners.Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatmentHealth outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinicUkrainian prisoners and community reentry challenges: implications for transitional care.Increased hospital and emergency department utilization by individuals with recent criminal justice involvement: results of a national surveyPredictors of reincarceration and disease progression among released HIV-infected inmatesWithin-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviourHIV treatment in US prisons.Jails as Public Health Partners: Incarceration and Disparities Among Medically Underserved MenThe impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected womenA cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocolDose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug usersHIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.A patient navigation intervention for drug-involved former prison inmates.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentryEffect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.Sexual HIV Risk Among Male Parolees and Their Female Partners: The Relate ProjectEmergency department utilization among recently released prisoners: a retrospective cohort study.
P2860
Q26865313-6F13E208-6E7A-4325-A630-25B33DFCE0BEQ27014885-B45CC40F-0BC0-4BE6-BB7D-014AA532532BQ28483957-AF398C0E-9066-48A6-8A13-ACB58CC7EB05Q28729018-932D1C12-35A7-4446-A0FE-D266811BA619Q30882906-A9C6199C-4585-44C7-B97F-1FC337480AA8Q31083101-C177E740-3DE6-411B-8760-9D2AB20EA8BAQ31154418-912AC3B5-CD59-4D61-8190-5F035EC42E9FQ33590169-B4F3AF9E-0056-49E1-8332-CAAF1F933624Q33614946-72198E38-44B3-4EFD-99CA-486927652AE1Q33640311-42578879-F5A9-4D99-AC2B-58963B75240EQ33640322-73C01953-653B-4413-9DF4-BD35DE67B456Q33674303-B24E0263-A43C-4B13-A38D-D592CB63D28CQ33691666-925C80B9-8D30-4D32-BA12-2F4CD78C1CA5Q33762748-0D3B7679-1AC5-4285-A1DA-42369A652693Q33769991-5BBABE43-BBD7-48E1-8AEB-0E4B5B919F9FQ33795852-1A6405E6-C8DB-495E-B17E-04F481167680Q33801159-B4D3B2B9-B819-4468-AFFA-4AFAE34ECA4DQ33819391-50F19F96-E2D2-4BB4-BE77-B69FC02C096DQ33853654-3C2B4235-78B3-4657-A7CD-D90CD7FEACF6Q33858977-3BD37AE2-3FF0-4B04-A51D-6B3634C1E9FDQ33859028-9F9AB75F-F056-448A-994E-8941B9CE81D8Q33977281-2929B13D-7E4E-4748-B420-9B5BC408C7E6Q34068472-EC971C2E-ED33-4DBC-943E-4CDBD75770CEQ34068801-B475373A-5928-4A0D-BA93-E58E8CBAA279Q34071478-1A436D87-EB54-4DAB-BA86-2D6676291E84Q34104877-AB5956D0-0578-4700-B684-408590FCBFC1Q34105570-0C5AB08B-E630-4B7A-B3AB-1D0F449C2B4FQ34193216-54178688-28F8-4B22-80F3-B47629B5D9D7Q34441493-E46795BA-E407-4386-B6F2-B1223703EEA8Q34591725-2D725BDE-45AD-4F80-8404-93CC62060F09Q34731476-44C0F98B-5A72-449C-ABB2-F02F80A59D0EQ34754918-C5BE0306-EEAA-4433-AFA2-891406E6B8FFQ34758927-D9B19780-C179-4A24-9AF0-5872B1703ED0Q34772591-3EA5DC9D-D990-417A-ACCD-2DEFB8DECDE4Q34817072-8F5EF881-B9C6-44A9-AE62-BB46680A0D63Q34890135-A1D261F2-E98C-42A6-AEB7-E06DB7EC2934Q34967941-1D8E168B-41C5-4387-81F1-71050B10A607Q35001897-45FFDC0B-8CC6-40A6-898F-4152DFF5067BQ35021567-E465127D-B380-4544-AD84-01F16285AC1EQ35031464-5E574EE9-E837-4A53-A6B8-3627A0B68AFB
P2860
Accessing antiretroviral therapy following release from prison.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Accessing antiretroviral therapy following release from prison.
@ast
Accessing antiretroviral therapy following release from prison.
@en
Accessing antiretroviral therapy following release from prison.
@nl
type
label
Accessing antiretroviral therapy following release from prison.
@ast
Accessing antiretroviral therapy following release from prison.
@en
Accessing antiretroviral therapy following release from prison.
@nl
prefLabel
Accessing antiretroviral therapy following release from prison.
@ast
Accessing antiretroviral therapy following release from prison.
@en
Accessing antiretroviral therapy following release from prison.
@nl
P2093
P2860
P356
P1476
Accessing antiretroviral therapy following release from prison
@en
P2093
Brad H Pollock
David P Paar
Jacques Baillargeon
Josiah D Rich
Katherine Wells
Z Helen Wu
P2860
P304
P356
10.1001/JAMA.2009.202
P407
P577
2009-02-01T00:00:00Z